WFRF:(Haider Syed)
Sökning: WFRF:(Haider Syed) > Patient educational...
- Haider, Syed Imran (författare)
Patient educational level and use of newly marketed drugs : a register-based study of over 600,000 older people
- Artikel/kapitelEngelska2008
Förlag, utgivningsår, omfång ...
- 2008-08-10
- Springer Science and Business Media LLC,2008
- printrdacarrier
Nummerbeteckningar
- LIBRIS-ID:oai:DiVA.org:su-57713
- https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-57713URI
- https://doi.org/10.1007/s00228-008-0549-8DOI
- http://kipublications.ki.se/Default.aspx?queryparsed=id:117900478URI
Kompletterande språkuppgifter
- Språk:engelska
- Sammanfattning på:engelska
Ingår i deldatabas
- SwePubSwePub
Klassifikation
Anmärkningar
- authorCount :5
- Objective To examine the association between educational level and the use of newly marketed drugs (NMD) among elderly persons. Methods We conducted a register-based, retrospective, cross-sectional study of 626,258 people aged 75-89 years who filled at least one drug prescription from August to October 2005 and who, consequently, were registered in the Swedish Prescribed Drug Register (SPDR). Data from the SPDR were record-linked to the Swedish National Inpatient Register and the Education Register. Newly marketed drugs were defined as new chemical entities that had been approved in Sweden between 2000 and 2004. Results Overall, NMD were prescribed to 7.3% of the study population. The use of NMD increased with increasing educational level (6.9% for the lowest educated elderly and 8.1% for the highest educated elderly), and education was associated with NMD [odds ratio (OR) 0.82; 95% confidence interval (CI)] 0.80-0.88 for <9 compared with >= 13 years of education) after adjustment for age, sex, type of residential area and number of dispensed drugs. Decreasing educational level was associated with a lower probability of using most of the NMD, especially oseltamivir (adjusted OR 0.16; 95% CI 0.12-0.22 for <9 years of education compared with >= 13 years of education) and ezetimibe. Conclusions This study suggests that education-related inequalities in NMD use may exist even in a healthcare system that claims to ensure a high degree of equity. Future research is required to explain why educational level influences the selection of new drugs and whether it has any impact on health outcomes.
Ämnesord och genrebeteckningar
- Education
- Elderly
- Equity
- New drugs
- Registers
- Socioeconomic position
- general-practitioners
- prescription
- polypharmacy
- inequalities
- medication
- rofecoxib
- adoption
- sweden
- health
- canada
- Social sciences
- Socialvetenskap
Biuppslag (personer, institutioner, konferenser, titlar ...)
- Johnell, KristinaKarolinska Institutet (författare)
- Weitoft, Gunilla Ringback (författare)
- Thorslund, MatsKarolinska Institutet,Stockholms universitet,Institutionen för socialt arbete - Socialhögskolan(Swepub:su)mthor (författare)
- Fastbom, JohanKarolinska Institutet (författare)
- Karolinska InstitutetInstitutionen för socialt arbete - Socialhögskolan (creator_code:org_t)
Sammanhörande titlar
- Ingår i:European Journal of Clinical Pharmacology: Springer Science and Business Media LLC64:12, s. 1215-12220031-69701432-1041
Internetlänk
Hitta via bibliotek
- European Journal of Clinical Pharmacology (Sök värdpublikationen i LIBRIS)
Till lärosätets databas
Hitta mer i SwePub
- Av författaren/redakt...
- Haider, Syed Imr ...
- Johnell, Kristin ...
- Weitoft, Gunilla ...
- Thorslund, Mats
- Fastbom, Johan
- Artiklar i publikationen
- European Journal ...
- Av lärosätet
- Stockholms universitet
- Karolinska Institutet
Sök utanför SwePub
- Sök vidare i:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - Nationella bibliotekssystem
- LIBRIS.kb.se
